It was looking like another miserable week right up to Friday afternoon, when
a £2,700 loss became a £2,183 gain. Although that's not even clawed back last
weeks losses, it's a whole lot better than I was expecting. The deficit
between cost and value narrowed to £35,845 and total portfolio value is
£81,657.
There was only one big loser this week, with IQE:IQE dropping 6% in my
ISA. The drops were smaller in the other accounts, but the recent positive
trend seems to have come to an abrupt halt. Even my ISA holding is 41% down,
and that was meant to be the short term "quick win" bought at a bargain price
for quick profit. The SIPP holding was bought in the peak of optimism and is
66% down.
APAX:Apax Global Alpha is one of my new magic formula shares, and
rather typically had halted its post-Covid recovery the second I bought them.
They increased 5% this week and so are worth more than I paid for them, but
commission charges mean they are still £1.36 underwater. I'm hoping they will
be green next week. The next dividend ex-date will be in early August with
payment in mid-September.
CAML:Central Asia Metals had a good week, climbing 7%. As my 2nd
largest holding that did wonders for my SIPP. They gave a very positive
update, but frustratingly didn't mention when they will review the postponed
dividend. Kazakhstan has re-imposed Covid lockdown after a recent spike, so I
can see why the board remain cautious. These are still 16% down, and such a
bargain I'm tempted to get some more.
FXPO:Ferrexpo is another one of my magic formula shares, and also
climbed 7% this week. It means they are only 2% down now and another I hope
will go into the green next week.
Share of the Week is SBTX:SkinBioTherapeutics which surged 10% in my
ISA and 14% in my SIPP. Unfortunately I sold my trading account holding just
before the surge, but more of that in the appropriate section. My SIPP holding
is up 25% and I need to start thinking about whether I stick to my plan to
take profits at 19.5p as it may happen next week. My ISA holding is still 7%
down. If anything that's the one I ought to consider selling at a smaller
profit just to clear the fact I bought them so expensive and hang fire for the
next dip. Selling them never really feels like selling them as I still have
such a big stake via OPTI:Optibiotix.
Always a relief to bounce off the injection line
Managed to prevent dipping below the trend line, but still following it down.
Here's the ISA and share portfolios
| Weekly Change | |||
| Cash |
£241.06 |
-£3.75 | |
| Portfolio cost | £62,090.24 | +£0 | |
| Portfolio sell value (bid price-commission) | £41,368.39 | (-33.4%) | +£892.20 |
| Potential profits | £0 | +£0 | |
| Yr 5 Dividends | £0.85 | +£0 | |
| Yr 5 Profit from sales | £-14.48 | +£0 | |
| Yr 5 Average monthly cash profit | -£4.85 | (-0.1%) | -£0.23 |
| Total Dividends | £1,343.15 | +£0 | |
| Total Profit from sales | £20,376.93 | +£0 | |
| Average monthly cash profit | £362.30 | (7.0%) | -£1.48 |
|
(Sold stocks profit + Dividends - Fees / Months) |
|||
| Performance/Injection | 10.4% | -0.1% | |
| Compound performance | 52% | +0% |
Cash dropped due to the monthly fee and I still have my £200 cash waiting on
the TLOU:Tlou Energy open offer. Most of the rise was due to
OPTI:Optibiotix climbing 1p, but given it was making a 3p loss until
Friday lunchtime that was a good week. I only have 3 weeks until the end of
year 5 and I'm still making a loss for the year. My best hope of getting into
positive territory is selling SBTX:SkinBioTherapeutics for a small
profit. 20.5p would do it, but given resistance is 20p I don't think it's
going to happen.
Still below the injection line, but only just.
Boing!
The SIPP looks like this after week 241
| Weekly Change | ||||
| Cash | £48.08 | -£14.27 | ||
| Portfolio cost | £53,058.85 | +£0 | ||
|
Portfolio sell value (bid price - commission) |
£38,878.30 | (-26.7%) | +£1,346.67 | |
| Potential profits | £420.27 | +£230.98 | ||
| Yr 5 Dividends | £28.67 | +£0 | ||
| Yr 5 Interest | £0.03 | +£0 | ||
| Yr 5 Profit from sales | £116.44 | +£0 | ||
| Yr 5 Average monthly cash profit | £4.38 | (0.1%) | -£2.06 | |
| Total Dividends | £1,927.91 | +£0 | ||
| Total Interest | £0.20 | +£0 | ||
| Total Profit from sales | £12,665.54 | +£0 | ||
| Average monthly cash profit | £252.42 | (5.7%) | -£1.31 | |
|
(Sold stocks profit + Dividends - Fees / Months) |
||||
| Performance/Injection | 8.6% | -0.1% | ||
| Compound performance | 40% | +0% |
Cash dropped due to the monthly fees, and portfolio value increased by much
more than the ISA thanks to the addition of
CAML:Central Asia Metals and my magic formula shares. Potential profits
are up by £230 thanks to SBTX:SkinBioTherapeutics and I'm sorely
tempted to cash it in next week and wait for the inevitable drop to increase
my holding.
As the cost goes up the value has been going down, so we're a long, long way
from being back in the black.
Another save from dipping below the trend line.
The trading account looks like this after week 207
| Weekly Change | |||
| Cash | £216.05 | +£0 | |
| Portfolio cost | £2,354.14 | +£0.03 | |
| Portfolio sell value (bid price - commission) | £1,410.84 | (-40.1%) | -£55.04 |
| Potential profits | £0 | -£30.72 | |
| Year 4 Dividends | £13.20 | +£0 | |
| Year 4 Profit | £350.66 | +£29.71 | |
| Yr 4 Average monthly cash profit | £30.92 | (15.8%) | +£1.96 |
| Dividends | £47.92 | +£0 | |
| Profit from sales | £286.37 | +£29.71 | |
| Average monthly cash profit | £7.00 | (3.6%) | +£0.59 |
|
(Sold stocks profit + Dividends - Fees / Months) |
I thought JLP:Jubilee Metals were about to surge after the recent dip,
and I thought SBTX:SkinBioTherapeutics was about to start slipping
again. I was wrong on both counts.
I sold my holding in SBTX:SkinBioTherapeutics for a measly £29.71
(5.6%) profit but would have made £97 if I'd waited until Friday. Meanwhile
the shares JLP:Jubilee Metals gave to Horizon for the recent tailings
deal were all sold off and the share price dipped further, although recovered
to 3.55p by the end of Friday. I bought 14,361 shares on Monday at 3.4815p
costing £511.93. They are only losing commission now, so I'm still hopeful
they will allow a relatively quick profit, especially if we get a trading
statement.
Next week is the final week of year 4 for this account, so whatever happens
I'm going to end up with over £30 a month (15.8%) average profit for the year.
That's exactly the sort of thing I hoped this account would generate, so I'm
very happy. It's a shame I've had to do that based on just £500 of my stake.
It makes me realise how much I could have made if the early decisions weren't
so dreadful.
Long term performance is now £7 a month over 4 years, which is 3.6%. Well
below my usual 10% target, but given I was loss making for the first 3 years
it's a lot better.
Slowly but steadily moving towards at least the injection line
That's it - the trend line is pointing upwards for the first time in forever!
Granted it's a hell of a long way below zero, but at least moving in the right
direction.
Last week the virtual magic formula portfolio was down 15.45% and this week
it's only down 14.84%. If next week's pension transfer takes me above £2,200
I'll need to do some number crunching to find out which two new shares to buy.
It's really tempting just to get another £2,000 worth of
CAML:Central Asia Metals though. The mind boggles at why those are
still so low.
Looking at last week's wishes, we still haven't had SweetBiotix news for
OPTI:Optibiotix. CAML:Central Asia Metals had a chance to
mention the dividend but didn't, so I'm scrubbing that off my wish list
until autumn. FXPO:Ferrexpo is not back in the black, but is getting
close so that wish will stay. SBTX:SkinBioTherapeutics got close to
19.5p but I'd already sold up my trading shares. I may still sell my SIPP if
they get there this week. JLP:Jubilee Metals did drop a little
allowing me to buy, so a fast rise is back on my wish list because of the
trading account, so I need a trading update and to hit 5p.
No comments:
Post a Comment